Skip to main content
OpenTrials
Completed

NCT Number: NCT04541966

What Happens to First Trimester Nuchal Translucency

First trimester nuchal translucency is a call point for genetic abnormalities and birth defects. Nuchal translucency varies with LCC and therefore with gestational age as described by Chung et al who created a 99th percentile curve of nuchal translucency versus LCC. The majority of centers use the 3.5 mm cutoff as the 99th percentile instead of using nuchal translucency based on LCC. The objective of this study is to compare the fate of nuchal hyperclites> = 99th p but <3.5mm versus 3.5mm. For this the investigators have studied the ultrasound and genetic abnormalities. The investigators were also interested in the pregnancy outcomes and the percentage of pregnancies in the group> = 99th p and <3.5mm that would have been sampled for a high combined risk for trisomy 21, and therefore to determine the benefit of a systematic sample. for HCN as well as the interest of performing an ACPA that would not be performed on a sample with a high risk of trisomy 21.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Sex eligibility

Female

Study type

Observational

Primary location

Uhmontpellier

Montpellier, 34295, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

nuchal translucency> = 99th percentile

Exclusion criteria

  • multiple pregnancies

Treatment and study plan

Primary outcomes

  1. Pregnancies without ultrasound or genetic abnormalities

    Time frame: immediate antenatal and postnatal period

    Pregnancies without ultrasound or genetic abnormalities

Secondary outcomes

  1. ACPA interest

    Time frame: immediate antenatal and postnatal period

    ACPA interest

  2. percentage of samples for high risk combined for trisomy 21

    Time frame: immediate antenatal and postnatal period

    percentage of samples for high risk combined for trisomy 21

  3. Pregnancy outcomes

    Time frame: immediate antenatal and postnatal period

    Pregnancy outcomes

Sponsors and collaborators

Lead sponsor

University Hospital, Montpellier

Other

Registry information

Official study title

What Happens to First Trimester Nuchal Translucency Greater Than or Equal 99ème Percentile and Inferior 3.5 mm

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
Sep 9, 2020
Registry last updated
Sep 10, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.